Skip to content
Screener

Accounts Payable at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$688.5M-13.2%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$54.2M-41.5%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$2.9M-43.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$7.53M
NeoGenomics logo
NeoGenomicsNEO
$20.95M-23.8%
Simulations Plus logo
Simulations PlusSLP
$2.23M+34.3%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except share amounts)As of / June 30,2026As of / December 31,2025
Total assets$2,057,181$1,975,472
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable (includes $0.1 million and $0.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)$37,527$28,142
Accrued expenses451,076408,382
Advanced billings (includes $13.1 million and $12.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)904,722854,390
Other current liabilities42,10452,834
Total current liabilities1,435,4291,343,748

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s accounts payable?
Medpace Holdings, Inc. (MEDP) reported accounts payable of $37.53M in Q2 2026.
How has Medpace Holdings, Inc.'s accounts payable changed year-over-year?
Medpace Holdings, Inc.'s accounts payable decreased by 13.3% year-over-year, from $43.28M to $37.53M.
What is the long-term trend for Medpace Holdings, Inc.'s accounts payable?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s accounts payable has grown at a 1.2% compound annual growth rate (CAGR), from $26.55M to $28.14M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Medpace Holdings, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude